These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6429722)

  • 1. The pertussis vaccine controversy.
    Hinman AR
    Public Health Rep; 1984; 99(3):255-9. PubMed ID: 6429722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
    Matter HC; Schmidt-Schläpfer G; Zimmermann H
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis vaccine--an analysis of benefits, risks and costs.
    Koplan JP; Schoenbaum SC; Weinstein MC; Fraser DW
    N Engl J Med; 1979 Oct; 301(17):906-11. PubMed ID: 39253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks of immunization against pertussis.
    Stuart-Harris C
    Dev Biol Stand; 1979; 43():75-83. PubMed ID: 520687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of pertussis and high expectations concerning vaccines].
    Wysocki J
    Przegl Epidemiol; 2004; 58 Suppl 1():39-43. PubMed ID: 15807156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postlicensure epidemiology of childhood vaccination: the Danish experience.
    Hviid A
    Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis outbreak in a basic school in Estonia: description, contributing factors and vaccine effectiveness.
    Torm S; Meriste S; Tamm E; Alusalu S; Järviste A; Lang K
    Scand J Infect Dis; 2005; 37(9):664-8. PubMed ID: 16126567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pertussis: a reemerging infection?].
    Kriz B; Fabiánová K; Maixnerová M; Benes C; Malý M
    Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):51-65. PubMed ID: 17593802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of pertussis vaccination in adults.
    Lee GM; Murphy TV; Lett S; Cortese MM; Kretsinger K; Schauer S; Lieu TA
    Am J Prev Med; 2007 Mar; 32(3):186-193. PubMed ID: 17296470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health perspectives on the rising incidence of pertussis.
    Judelsohn RG; Koslap-Petraco MB
    Public Health Nurs; 2007; 24(5):421-8. PubMed ID: 17714226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acellular pertussis vaccines: a turning point in infant and adolescent vaccination.
    Rappuoli R
    Infect Agents Dis; 1996 Jan; 5(1):21-8. PubMed ID: 8789596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Whooping cough and whooping cough vaccination - a dilemma of the vaccination policy].
    Taranger J
    Lakartidningen; 1982 May; 79(19):1935-8. PubMed ID: 7132489
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whooping cough and pertussis vaccine: a comparison of risks and benefits in Britain during the period 1968-83.
    Stewart GT
    Dev Biol Stand; 1985; 61():395-405. PubMed ID: 3835080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of risk and benefit in immunization against pertussis and tuberculosis.
    Ambrosch F; Wiedermann G
    Dev Biol Stand; 1979; 43():85-90. PubMed ID: 520688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination.
    Orenstein WA
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S147-50. PubMed ID: 10447034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of pertussis and pertussis vaccination in Finland.
    Mertsola J; Viljanen MK; Ruuskanen O
    Ann Clin Res; 1982 Dec; 14(5-6):253-9. PubMed ID: 7171232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.